| Date | Time | Source | Headline | Symbol | Company |
| 30/04/2019 | 12:00 | GlobeNewswire Inc. | ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual Meeting | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 12/03/2019 | 20:01 | GlobeNewswire Inc. | Harrow Health Announces Fourth Quarter 2018 Financial Results | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 04/03/2019 | 12:00 | GlobeNewswire Inc. | Harrow Health to Attend 31st Annual ROTH Conference on March 18, 2019 | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 28/02/2019 | 12:00 | GlobeNewswire Inc. | Harrow Health to Announce Fourth Quarter 2018 Financial Results on March 12, 2019 | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 13/02/2019 | 12:00 | GlobeNewswire Inc. | Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/02/2019 | 12:00 | GlobeNewswire Inc. | Harrow Health Subsidiary, Mayfield Pharmaceuticals, Inc., Acquires Patented Dyspareunia Drug Candidate and Other Intellectual... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/02/2019 | 12:00 | GlobeNewswire Inc. | Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals Subsidiary | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/01/2019 | 22:27 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 31/12/2018 | 12:01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 31/12/2018 | 12:00 | GlobeNewswire Inc. | Imprimis Pharmaceuticals, Inc. Completes Name Change to Harrow Health, Inc. | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 17/12/2018 | 11:29 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/12/2018 | 11:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 16/11/2018 | 12:30 | GlobeNewswire Inc. | Imprimis Pharmaceuticals Ranked 88th Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500™ | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 13/11/2018 | 21:23 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 13/11/2018 | 21:22 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 13/11/2018 | 21:01 | GlobeNewswire Inc. | Imprimis Pharmaceuticals Announces Third Quarter 2018 Results | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 13/11/2018 | 17:01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/11/2018 | 12:16 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/11/2018 | 12:00 | GlobeNewswire Inc. | Imprimis Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 13, 2018 | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 02/11/2018 | 22:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 29/10/2018 | 10:13 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 23/10/2018 | 12:00 | GlobeNewswire Inc. | Imprimis Pharmaceuticals’ Subsidiary Melt Pharmaceuticals Initiates Clinical Development Program for its Patented Non-Opioi... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 18/10/2018 | 14:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 16/10/2018 | 12:00 | GlobeNewswire Inc. | ImprimisRx to feature new formulation and poster presentation on MKO Melt® at the upcoming American Academy of Ophthalmology... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/09/2018 | 22:33 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/09/2018 | 00:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 15/08/2018 | 12:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 13/08/2018 | 11:16 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/08/2018 | 12:05 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/08/2018 | 21:22 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |